文献速递肿瘤 PET/CT

基于PROMISE标准评估[68Ga]Ga-PSMA-I&T PET/CT在前列腺特异性抗原复发中附加骨盆延迟扫描的价值

Evaluation of [68 Ga]Ga-PSMA-I&T PET/CT with additional late scans of the pelvis in prostate-specific antigen recurrence using the PROMISE criteria.
PubMed 文献 · EJNMMI Res · 2022-10-09

该回顾性研究纳入297例前列腺切除术后PSA升高患者,比较早期全身[68Ga]Ga-PSMA-I&T PET/CT与附加骨盆延迟扫描。延迟扫描检出更多病灶且SUVmax与背景比值显著升高,使19.5%病例的miTNM分期发生改变。

要点

  • 延迟骨盆扫描检出191/195个病灶(97.9%),早期扫描正确识别144个(73.8%)。
  • 延迟扫描病灶SUVmax中位数3.9 vs 早期3.4,SUVmax/背景比值中位数15.5 vs 9.4,均显著升高(p<0.01)。
  • 与最终共识相比,早期扫描miTNM分期在58例(19.5%)中发生改变。

核心结论

  • 附加骨盆延迟扫描较早期扫描检出更多病灶且对比度增加,对最终miTNM分期产生实质影响。

研究设计与样本

  • 回顾性研究纳入297例前列腺切除术后PSA升高患者(中位PSA 0.35 ng/ml,IQR 0.2-0.8),均行早期全身[68Ga]Ga-PSMA-I&T PET/CT(中位剂量141 MBq,IQR 120-163;中位86分钟,IQR 56-107)及附加骨盆延迟扫描(中位180分钟,IQR 170-191)。

主要发现

  • 134例(45.1%)[68Ga]Ga-PSMA-I&T PET/CT显示复发性前列腺癌证据(早期114例/38.4%,延迟131例/44.1%)。
  • 195个病灶中,早期扫描正确识别144个(73.8%),延迟扫描检出191个(97.9%)。
  • 病灶SUVmax中位数早期3.4(IQR 0.4-6.5)vs 延迟3.9(IQR 2.6-8.2),SUVmax/背景比值中位数早期9.4(IQR 1.7-19.1)vs 延迟15.5(IQR 9.6-34.1),两时间点间均显著升高(p<0.01)。
  • 与最终共识相比,早期扫描miTNM分期在58例(19.5%)中改变:31例(10.4%)早期阴性(T0 N0 M0)被上调分期;27例(9.1%)早期有前列腺癌特征性病灶(>T0 N0 M0)被上调和/或下调分期;4例(1.3%)仅早期PET/CT可检出前列腺癌相关病灶导致延迟扫描上调分期。

关键数值与推荐

  • 早期与延迟图像分别按PROMISE标准分期,并与两者最终共识比较。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: PSMA PET/CT is the recommended imaging test in cases with prostate-specific antigen (PSA) recurrence after primary therapy of prostate cancer (PCa). However, imaging protocols remain a topic of active research. The aim of the presented study was to examine the impact of additional late scans of the pelvis in [68 Ga]Ga-PSMA-I&T PET/CT of patients with rising PSA after prostatectomy. METHODS: A total of 297 patients (median PSA 0.35 ng/ml, interquartile range (IQR) 0.2-0.8) who underwent early whole-body [68 Ga]Ga-PSMA-I&T PET/CT (median dose 141 MBq, IQR 120-163; median 86 min, IQR 56-107) and additional late scans of the pelvis (median 180 min, IQR 170-191) were investigated retrospectively. Early and late images were staged separately according to the PROMISE criteria and compared with a final consensus of both. Standardized uptake values were analyzed for early and late scans. RESULTS: One hundred and thirty-four (45.1%) [68 Ga]Ga-PSMA-I&T PET/CT showed evidence of recurrent PCa (114/38.4% early, 131/44.1% late). Of 195 lesions, 144 (73.8%) were identified correctly on early scans. 191 (97.9%) lesions were detected on late imaging. The lesion SUVmax (median 3.4, IQR 0.4-6.5 vs. median 3.9, IQR 2.6-8.2) as well as the SUVmax to background ratio (median 9.4, IQR 1.7-19.1 vs. median 15.5, IQR 9.6-34.1) increased significantly between the imaging time points (p < 0.01, respectively). Compared to the final consensus, the miTNM-staging of early scans changed in 58 (19.5%) cases. Of these, 31 patients (10.4%) with negative early scans (T0 N0 M0) were upstaged. Twenty-seven (9.1%) patients with PCa characteristic lesions on early imaging (> T0 N0 M0) were up- and/or downstaged. In 4 (1.3%) cases, PCa-related lesions were only detectable on early PET/CT leading to upstagings of late imaging. CONCLUSIONS: Additional late scans of the pelvis in [68 Ga]Ga-PSMA-I&T PET/CT detected more lesions and an increasing contrast compared to early imaging. This influenced the final miTNM-staging substantially.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Koehler D, Sauer M, Karimzadeh A, et al. Evaluation of [68 Ga]Ga-PSMA-I&T PET/CT with additional late scans of the pelvis in prostate-specific antigen recurrence using the PROMISE criteria. EJNMMI Res. 2022. PMID: 36210356. doi:10.1186/s13550-022-00938-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。